The Journal of the Korean life insurance medical association (보험의학회지)
- Volume 32 Issue 2
- /
- Pages.33-38
- /
- 2013
- /
- 1976-264X(pISSN)
Review of the coronary artery disease in terms of insurance medicine
관상동맥질환의 보험의학적 이해
- Lee, Sinhyung (Ansim paramedic)
- 이신형 (안심파라메딕)
- Received : 2013.06.30
- Accepted : 2013.10.31
- Published : 2013.11.26
Abstract
Coronary artery diseases are very important agenda in the insurance medicine. Insurance medicine is defined as using medical knowledge for insurance administration such as underwriting, claims, and customer satisfaction. This review article contains review of coronary artery disease in terms of insurance medicine. Estimation of extra-risks for acute myocardial infarction are MR of 349% and EDR of 41‰. In medical underwriting, individual life applicants can be assessed by Framingham's CHD risk assessment model. In claims, medical claims review is a useful method of consulting for claims staffs. Several diagnostic criteria of acute myocardial infarction are introduced in time. The universal definition of myocardial infarction by ESC/ACCF/WHF was demonstrated the most valuable predictor of 10-year mortality. Contents for State-Of-The-Art of the coronary artery disease are current antithrombotics. There are many novel anti-thrombotic agents such as ticagrelol, dabigatran, rivaroxaban, and pegnivacogin.